These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 15818511

  • 1. Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus.
    Jin O, Sun LY, Zhou KX, Zhang XS, Feng XB, Mok MY, Lau CS.
    Clin Rheumatol; 2005 Apr; 24(2):107-10. PubMed ID: 15818511
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V, Singh AP, Aggarwal A, Naik S, Misra R.
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms.
    Robak E, Sysa-Jedrzejowska A, Robak T, Smolewski P.
    Clin Rheumatol; 2006 Mar; 25(2):225-33. PubMed ID: 16432661
    [Abstract] [Full Text] [Related]

  • 9. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 10. Keratinocyte and lymphocyte apoptosis: relation to disease outcome in systemic lupus erythematosus patients with and without cutaneous manifestations.
    Salem SA, Farouk HM, Mostafa AA, Hassan IM, Osman WM, Al-Shamy HA, Assaf NY.
    Eur J Dermatol; 2010 Feb; 20(1):35-41. PubMed ID: 19919906
    [Abstract] [Full Text] [Related]

  • 11. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M, van Lopik T, Limburg PC, Spronk PE, Jaegers SM, Aarden LA, Smeenk RJ, Kallenberg GG.
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Su DL, Wang HJ, Ji XH, Li YY, Xuan HB, Heng C, Li YF.
    Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
    [Abstract] [Full Text] [Related]

  • 13. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
    Wu Q, Yang Q, Lourenco E, Sun H, Zhang Y.
    Arthritis Res Ther; 2011 Jun 16; 13(3):R88. PubMed ID: 21679442
    [Abstract] [Full Text] [Related]

  • 14. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
    Bahrehmand F, Vaisi-Raygani A, Kiani A, Rahimi Z, Tavilani H, Ardalan M, Vaisi-Raygani H, Shakiba E, Pourmotabbed T.
    Lupus; 2015 May 16; 24(6):597-605. PubMed ID: 25416694
    [Abstract] [Full Text] [Related]

  • 15. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus.
    Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M.
    Lupus; 1998 May 16; 7(2):113-8. PubMed ID: 9541096
    [Abstract] [Full Text] [Related]

  • 16. [Increased serum C-C chemokine ligand 19 levels correlated with B cell abnormalities in systemic lupus erythematosus].
    Liu HJ, Shi LJ, Hu FL, Yao HH, Li ZG, Jia Y.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct 18; 49(5):829-834. PubMed ID: 29045964
    [Abstract] [Full Text] [Related]

  • 17. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA.
    Cytokine; 2015 Apr 18; 72(2):146-53. PubMed ID: 25647269
    [Abstract] [Full Text] [Related]

  • 18. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M, Liu J, Hao S, Wu P, Zhang X, Xiao Y, Jiang G, Huang X.
    Clin Rheumatol; 2018 Oct 18; 37(10):2675-2684. PubMed ID: 29774490
    [Abstract] [Full Text] [Related]

  • 19. [Interferon-α mediating the functional damage of CD56dimCD57+natural killer cells in peripheral blood of systemic lupus erythematosuss].
    Zhao XG, Liu JQ, Huang HN, Lu ZM, Bai ZR, Li X, Qi JJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec 18; 55(6):975-981. PubMed ID: 38101777
    [Abstract] [Full Text] [Related]

  • 20. Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsets.
    Yamamoto N, Yamaguchi H, Ohmura K, Yokoyama T, Yoshifuji H, Yukawa N, Kawabata D, Fujii T, Morita S, Nagata S, Mimori T.
    Lupus; 2014 Apr 18; 23(4):386-94. PubMed ID: 24554711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.